descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2023 English Publisher:Elsevier BVJournal:Primary Care: Clinics in Office Practice, volume 50, pages 191-203 (issn: 0095-4543,

Authors: Karl T, Clebak; Leesha, Helm; Prabhdeep, Uppal; Christopher R, Davis; Matthew F, Helm;

doi: 10.1016/j.pop.2022.12.004 , 10.1016/j.mcna.2023.08.012

pmid: 38816108 , 37105601

Atopic Dermatitis

- Summary
- Subjects
- Metrics

Abstract

Atopic dermatitis (AD) is a common, chronic relapsing, and remitting inflammatory skin disease that is characterized by erythematous, scaly, and pruritic lesions often located over the flexural surfaces. Treatment goals of AD include the reduction of itching and burning, as well as the reduction of skin changes. Treatment of AD includes emollients and skin care, topical therapies including topical corticosteroids and steroid-sparing therapies, systemic therapies, and phototherapy.

Related Organizations

Penn State Milton S. Hershey Medical Center
United States

Keywords

Emollients, Adrenal Cortex Hormones, Humans, Dermatologic Agents, Phototherapy, Skin Care, Glucocorticoids, Skin, Dermatitis, Atopic

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	21
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%